<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bueno O</dc:creator>
  <dc:creator>Estévez Gallego J</dc:creator>
  <dc:creator>Martins S</dc:creator>
  <dc:creator>Prota AE</dc:creator>
  <dc:creator>Gago F</dc:creator>
  <dc:creator>Gómez-SanJuan A</dc:creator>
  <dc:creator>Camarasa MJ</dc:creator>
  <dc:creator>Barasoain I</dc:creator>
  <dc:creator>Steinmetz MO</dc:creator>
  <dc:creator>Díaz JF</dc:creator>
  <dc:creator>Pérez-Pérez MJ</dc:creator>
  <dc:creator>Liekens S</dc:creator>
  <dc:creator>Priego EM</dc:creator>
  <dc:date>2018</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Microtubule-targeting agents that bind at the colchicine-site of tubulin are of particular interest in antitumoral therapy due to their dual mechanism of action as antimitotics and vascular disrupting agents. Cyclohexanediones derivatives have been described as a new family of colchicine-domain binders with an association constant to tubulin similar to that of colchicine. Here, the high-resolution structures of tubulin in complex with cyclohexanediones TUB015 and TUB075 were solved by X-ray crystallography. A detailed analysis of the tubulin-TUB075 interaction by means of computational affinity maps allowed the identification of two additional regions at the binding site that were addressed with the design and synthesis of a new series of cyclohexanediones with a distal 2-substituted benzofurane. These new compounds showed potent antiproliferative activity with IC50 values in the nM range, arrested cell cycle progression at the G2/M phase and induced apoptosis at sub μM concentrations. Moreover, they caused the destruction of a preformed vascular network in vitro and inhibited the migration of endothelial cells at non-toxic concentrations. Finally, these compounds displayed high affinity for tubulin as substantiated by a K b value of 2.87 × 108 M-1 which, to the best of our knowledge, represents the highest binding constant measured to date for a colchicine-domain ligand.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/296033</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-018-22382-x</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/29523799</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Scientific reports. - 2018</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Binding Sites</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Cell Line</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Cell Line, Tumor</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Cell Movement</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Colchicine</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cyclohexanones</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Endothelial Cells</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Ligands</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Molecular Docking Simulation</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Protein Binding</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Tubulin</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Tubulin Modulators</dc:subject>
  <dc:title xmlns:ns14="xml" ns14:lang="en">High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
